• FY25 revenue of $40.8M, up 10% year-over-year
• Annual Recurring Revenue (ARR) of $28.5M, up 31% year-over-year
• Record Underlying EBITDA of $5.1M, up from a $3.4M loss in FY24

Alcidion Group Ltd, a leading healthcare software and informatics company, has reported its FY25 results, showcasing strong momentum and increasing scale. The company delivered record financial performance, with revenue of $40.8M, up 10% year-over-year. This was driven by several new contract wins, including a milestone $39M+ contract with North Cumbria NHS Trust in the UK for a new Electronic Patient Record (EPR) solution. Alcidion's Annual Recurring Revenue (ARR) also grew significantly, reaching $28.5M as of June 2025, up 31% year-over-year. This underpins the company's future profitability and growth. Alcidion also reported a record Underlying EBITDA of $5.1M, a significant turnaround from the $3.4M loss in the prior year. This was achieved through disciplined cost management, with staff costs and total operating costs (excluding foreign exchange gains) down 10% year-over-year. The company's strong financial profile is further supported by a healthy balance sheet, with $17.7M in cash as of June 2025. Alcidion's platform technology, Miya Precision, continues to drive the company's growth, transforming data interoperability and software integration to streamline patient flow, unify patient records, support clinical decision-making, and scale remote patient monitoring. The company has also strengthened its leadership team with key appointments, positioning it well to deliver on its future growth strategy.

Alcidion expects FY26 starting contracted revenue of $34M, which will increase further with additional contract wins during the year. The company's platform technology, Miya Precision, is expected to continue driving growth through new feature deployments and geographical expansion.

Alcidion is well-positioned to accelerate its global growth, with the building blocks in place, including a strong financial profile, a growing recurring revenue base, and a validated platform technology that addresses the pressing needs of healthcare systems operating under increasing pressure to improve efficiency.